Rajeev Mohan is the Director of Program Management at Jubilant Therapeutics Inc., and has 18+ years of diverse pharmaceutical experience encompassing business strategy, portfolio selection, commercial operations, manufacturing and R&D.
Most recently, Rajeev managed consulting engagements in areas of strategic planning, new opportunities evaluation, and commercial operations. Prior to this, Rajeev was part of Vensun Pharma's executive team managing it's organic and inorganic growth, including multiple equity and debt financing rounds. Early on, Rajeev successfully transitioned from a technical to a commercial role at URL Pharma (now Takeda) and Andrx Pharma (now Teva).
Rajeev holds an MBA from Cornell University, a Doctorate in Chemical Engineering from NYU, and a Bachelors in Chemical Engineering from Osmania University, India.